助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   乳腺癌化疗 的翻译结果: 查询用时:0.249秒
图标索引 在分类学科中查询
所有学科
外科学
临床医学
更多类别查询

图标索引 历史查询
 

乳腺癌化疗
相关语句
  breast cancer chemotherapy
     C-erbB-2-future biological marker of breast cancer chemotherapy
     c-erbB-2—未来乳腺癌化疗的生物学标志物
短句来源
     Study on the strategies of domestic rhG-CSF in preventing neutropenia caused by breast cancer chemotherapy
     国产rhG-CSF预防乳腺癌化疗后中性粒细胞减少症的应用策略
短句来源
     Clinical Observations on RHuEPO in the Treatment of Breast Cancer Chemotherapy Realated Anemia
     人促红细胞生成素治疗乳腺癌化疗相关性贫血
短句来源
     Health education requirement in patients with breast cancer chemotherapy
     乳腺癌化疗患者健康教育需求探讨
短句来源
     Results From the best to worst,th e status of QOL in breast cancer chemotherapy patients was:pretherapy,postther ap y and during-therapy.
     结果乳腺癌化疗患者的生存质量状况以化疗前最好,化疗后次之,化疗中最差。
短句来源
更多       
  “乳腺癌化疗”译为未确定词的双语例句
     Methods:52 Soaked mammary cancer cases were treated with 3 schemes respectively, and scheme A is AT, scheme B is XT , scheme C is GT.
     方法:对52例复发或转移性乳腺癌化疗患者分别采用3种给药方案治疗,方案A为AT方案,方案B为XT方案,方案C为GT方案,治疗2个周期评价疗效。
短句来源
     Conclusions CerbB2 and PCNA might be valuable factors in predicting chemotherapy efficacy in breast cancer.
     结论C-erbB2与PCNA可作为预测乳腺癌化疗疗效的有价值的指标。
短句来源
     Methods Ninety-five patients with advanced breast cancer received this regimen(50 mg/m2 of THP or 70 mg/m2 of E-ADM intravenous infusion for 15 min,day 1;135-175 mg/m2 of paclitaxel,intravenous infusion for 3 hr,day 2),every 21 days was a cycle.
     方法95例患者均为晚期乳腺癌,化疗方案为THP 50 mg/m2或E-ADM70 mg/m2,快速静滴15 m in,d1; 国产紫杉醇135~175 mg/m2,静滴3 h,d2。
短句来源
     Conclusions combining examination of P-gp,LRP, GST-π and TOPO-Ⅱ may have an instmctive significant for Chemotherapy of breast cancer.
     结论 :P gp、LRP、GST π、TOPO Ⅱ的耐药机制各不相同 ,同时检测P gp、LRP、GST π、TOPO Ⅱ等多种导致多药耐药的因素 ,对乳腺癌化疗有重要的指导意义。
短句来源
     Overexpression of c erbB 2 in breast cancer is associated with resistance or sensitivity to certain chemo therapeutic drugs, c erbB 2 can be expected to be a biological marker to direct chemotherapy in the treatment of breast cancer.
     乳腺癌病人c erbB 2过表达提示对某些化疗药物的耐受性或敏感性 ,c erbB 2可望作为乳腺癌化疗的生物学标志物 ,用于指导临床化疗
短句来源
更多       
  相似匹配句对
     Neoadjuvant of Breast Cancer
     乳腺癌新辅助化疗
短句来源
     Neo-adjuvant chemotherapy for breast cancer
     乳腺癌新辅助化疗初探
短句来源
     Chemoprevention of breast cancer
     乳腺癌的药物预防
短句来源
查询“乳腺癌化疗”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  breast cancer chemotherapy
Conclusions: The results corroborate the hypothesis that fatty acid synthase may be a target of breast cancer chemotherapy and suggest that inhibitors of the enoyl-reductase partial activity of fatty acid synthase may have chemotherapeutic potential.
      
Panmucositis and chemosensitisation associated with betel quid chewing during dose-dense adjuvant breast cancer chemotherapy
      
Vinorelbine and the topoisomerase 1 inhibitors: Current and potential roles in breast cancer chemotherapy
      
Changes in body composition during breast cancer chemotherapy with the CMF‐regimen
      
Our data suggest the use of 4625 as a potent adjuvant in breast cancer chemotherapy.
      
更多          


In this article 85 patients with breast cancer wno were treated with chemotherapy from September 1982 to August 1986 were reported.Twenty-eight them were added wlth polya- ctin-A,27 with Interferon and 30 with Hopacorin,pentoxylum and vitamin B to be as controls.The results showed that the adding immunenhancers have better enhancemeut and regulatory effects on chemotherapy in breast carcinoma.The values of several immunoassa- ys were increased,and the values of few immunoassays were decreased,but the decreasi-...

In this article 85 patients with breast cancer wno were treated with chemotherapy from September 1982 to August 1986 were reported.Twenty-eight them were added wlth polya- ctin-A,27 with Interferon and 30 with Hopacorin,pentoxylum and vitamin B to be as controls.The results showed that the adding immunenhancers have better enhancemeut and regulatory effects on chemotherapy in breast carcinoma.The values of several immunoassa- ys were increased,and the values of few immunoassays were decreased,but the decreasi- ng was less obvius than that of the controls. The survival rata of the test group is 78.18%,and that of the cnntrols was 43.33%. The disparity was highly significant (P<0.01).

报告我院1982.9~1986.8期间收治的乳腺癌患者,给予化疗者85例,其中加用多抗甲素治疗28例、干扰素治疗27例。与对照组比较,发现加用免疫增强剂,对乳腺癌化疗具有较好的增强和词节作用,多项指标均有增强。治疗组的生存率达78.18%,明显高于对照组生存率43.33%(P<0.01),具有高度显著性差异。

Abstract The clinical usefulness of Recombinant

研究观察了基因重组人粒细胞集落刺激因子(rhG—CSF)对恶性淋巴瘤、肺癌及乳腺癌化疗后,白细胞和中性粒细胞减少的防治作用。化疗过程中,白细胞降至4.0×109/L以下时入组,并做为对照周期。其后的化疗周期化疗药物未次给药结束后48小时起,皮下注射rhG—CSF(75μg·次·天-1)。结果表明,rhG—CSF可以明显减轻化疗过程中白细胞下降的程度、缩短白细胞在4.0×10机以下的持续时间及恢复到4.0×109/L以上的时间。rhG—CSF对中性粒细胞的作用与白细胞相似,其毒副反应轻微,安全可靠。

This

本文报道了用抗癌新药卡莫氟治疗14例乳腺癌的结果。单药治疗6例,联合方案治疗8例,治疗有效率均为50%。主要毒副反应为骨髓抑制和胃肠道反应,多限于Ⅰ~Ⅱ度。结果表明,卡臭氟是一种有前途的治疗乳腺癌的化疗新药。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关乳腺癌化疗的内容
在知识搜索中查有关乳腺癌化疗的内容
在数字搜索中查有关乳腺癌化疗的内容
在概念知识元中查有关乳腺癌化疗的内容
在学术趋势中查有关乳腺癌化疗的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社